ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 1 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $14,000 | +75.0% | 40,000 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -11.1% | 40,000 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | 0.0% | 40,000 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -10.0% | 40,000 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -47.4% | 40,000 | 0.0% | 0.00% | – |
| Q1 2019 | $19,000 | +26.7% | 40,000 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -50.0% | 40,000 | 0.0% | 0.00% | – |
| Q3 2018 | $30,000 | +15.4% | 40,000 | 0.0% | 0.00% | – |
| Q2 2018 | $26,000 | +73.3% | 40,000 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | -44.4% | 40,000 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | +17.4% | 40,000 | 0.0% | 0.00% | – |
| Q3 2017 | $23,000 | -53.1% | 40,000 | 0.0% | 0.00% | – |
| Q2 2017 | $49,000 | -18.3% | 40,000 | 0.0% | 0.00% | – |
| Q1 2017 | $60,000 | +71.4% | 40,000 | 0.0% | 0.00% | – |
| Q4 2016 | $35,000 | -35.2% | 40,000 | 0.0% | 0.00% | – |
| Q3 2016 | $54,000 | -23.9% | 40,000 | 0.0% | 0.00% | – |
| Q2 2016 | $71,000 | -11.2% | 40,000 | 0.0% | 0.00% | – |
| Q1 2016 | $80,000 | -38.0% | 40,000 | 0.0% | 0.00% | – |
| Q4 2015 | $129,000 | +81.7% | 40,000 | 0.0% | 0.00% | – |
| Q3 2015 | $71,000 | -33.0% | 40,000 | 0.0% | 0.00% | – |
| Q2 2015 | $106,000 | -52.3% | 40,000 | 0.0% | 0.00% | – |
| Q1 2015 | $222,000 | 0.0% | 40,000 | 0.0% | 0.00% | – |
| Q4 2014 | $222,000 | -17.2% | 40,000 | 0.0% | 0.00% | – |
| Q3 2014 | $268,000 | -7.3% | 40,000 | 0.0% | 0.00% | – |
| Q2 2014 | $289,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |